SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-1.15%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$34.7M
AUM Growth
+$34.7M
(-88%)
Cap. Flow
-$261M
Cap. Flow
% of AUM
-754.3%
Top 10 Holdings %
Top 10 Hldgs %
75.76%
Holding
37
New
6
Increased
–
Reduced
18
Closed
12
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$1.78M |
| 2 |
Gilead Sciences
GILD
|
$1.58M |
| 3 |
McKesson
MCK
|
$1M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$534K |
| 5 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
$338K |
Top Sells
| 1 |
AstraZeneca
AZN
|
$24.1M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
$19.5M |
| 3 |
Sanofi
SNY
|
$17.4M |
| 4 |
Pfizer
PFE
|
$15.5M |
| 5 |
Viatris
VTRS
|
$14.8M |
Sector Composition
| 1 | Healthcare | 91.91% |
| 2 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novartis
NVS
$248B
| – | – |
-127,300
| Closed | -$10.3M |
|
27
Medtronic
MDT
$118B
| – | – |
-159,850
| Closed | -$12.8M |
|
28
Ironwood Pharmaceuticals
IRWD
$201M
| – | – |
-649,824
| Closed | -$10M |
|
29
Exact Sciences
EXAS
$9.33B
| – | – |
0
| – | – |
|
30
Cencora
COR
$57.2B
| – | – |
-57,600
| Closed | -$4.97M |
|
31
Bristol-Myers Squibb
BMY
$96.7B
| – | – |
-81,600
| Closed | -$5.16M |
|
32
Amgen
AMGN
$153B
| – | – |
-59,300
| Closed | -$10.1M |
|
|
AET
33
DELISTED
Aetna Inc
AET
| – | – |
-43,900
| Closed | -$7.42M |
|
|
NXTM
34
DELISTED
NxStage Medical Inc.
NXTM
| – | – |
-208,480
| Closed | -$5.18M |
|
|
AERI
35
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| – | – |
-70,668
| Closed | -$3.83M |
|
|
SIEN
36
DELISTED
Sientra, Inc.
SIEN
| – | – |
-529,210
| Closed | -$5.11M |
|
37
Dr. Reddy's Laboratories
RDY
$11.8B
| – | – |
-295,132
| Closed | -$9.65M |
|